Status:
RECRUITING
Changes in Regional and Global Cardiac Contractility After Stimulation in Scar Zone with the NOGA System
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Despite a decrease in voltage amplitude in post-infarction scar areas, greater voltage amplitudes are sometimes observed at the time of local extrasystoles mechanically induced by catheters. However,...
Eligibility Criteria
Inclusion
- \- Patients who should undergo ventricular tachycardia (VT) ablation after a myocardial infarction according to current recommendations, namely: patients with ischemic heart disease (ICD) and with episodes of sustained ventricular tachycardia responsible for internal electric shocks by the implantable automatic defibrillator (ICD) (grade IB recommendation)
- OR
- patients with an MIC and an ICD, presenting a first episode of sustained ventricular tachycardia (grade IIa, B recommendation)
- Affiliated with a social protection scheme
- Having signed an informed consent
Exclusion
- Contraindication or non-indication for ventricular tachycardia ablation
- Women who are pregnant or of childbearing age and without contraception, breastfeeding women
- Patients without ischemic heart disease
- Patients under guardianship, curatorship or legal protection.
Key Trial Info
Start Date :
February 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04757168
Start Date
February 23 2022
End Date
December 31 2025
Last Update
October 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ROLLIN Anne
Toulouse, CHU de Toulouse, France, 31059